Total Payments
$5,672
2023 Payments
$160.76
Companies
27
Transactions
251
Medicare Patients
9,499
Medicare Billing
$617,047
Payment Breakdown by Category
Food & Beverage$3,700 (65.2%)
Research$1,952 (34.4%)
Education$19.62 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,700 | 243 | 65.2% |
| Unspecified | $1,952 | 7 | 34.4% |
| Education | $19.62 | 1 | 0.3% |
Payments by Type
General
$3,720
244 transactions
Research
$1,952
7 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $2,069 | 15 | $0 (2019) |
| Novo Nordisk Inc | $511.19 | 44 | $0 (2019) |
| GlaxoSmithKline, LLC. | $448.10 | 29 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $442.85 | 27 | $0 (2019) |
| Lilly USA, LLC | $316.53 | 17 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $280.06 | 17 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $275.09 | 18 | $0 (2019) |
| PFIZER INC. | $226.09 | 13 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $179.30 | 12 | $0 (2019) |
| Dexcom, Inc. | $141.14 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $160.76 | 2 | Dexcom, Inc. ($141.14) |
| 2019 | $619.50 | 44 | AstraZeneca Pharmaceuticals LP ($125.44) |
| 2018 | $1,304 | 103 | Novo Nordisk Inc ($220.51) |
| 2017 | $3,587 | 102 | Allergan Inc. ($1,973) |
All Payment Transactions
251 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2023 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Food and Beverage | In-kind items and services | $141.14 | General |
| Category: Endocrinology | ||||||
| 09/14/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Education | In-kind items and services | $19.62 | General |
| Category: Cardio-renal | ||||||
| 10/25/2019 | Allergan Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/02/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Central Nervous System (CNS) | ||||||
| 08/01/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/25/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/24/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/18/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Diabetes | ||||||
| 06/27/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Diabetes | ||||||
| 06/26/2019 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $4.77 | General |
| Category: Respiratory | ||||||
| 06/25/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: RESPIRATORY | ||||||
| 06/20/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/17/2019 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: VACCINES | ||||||
| 06/06/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET XR, STEGLATRO | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/04/2019 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 05/28/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: RESPIRATORY | ||||||
| 05/15/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Diabetes | ||||||
| 05/14/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: RESPIRATORY | ||||||
| 05/14/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $5.37 | General |
| Category: Central Nervous System (CNS) | ||||||
| 05/13/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $1.09 | General |
| Category: Central Nervous System (CNS) | ||||||
| 05/13/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $0.88 | General |
| Category: Central Nervous System (CNS) | ||||||
| 05/02/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/12/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Obesity | ||||||
| 04/09/2019 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A MULTICENTER, RANDOMIZED, OPEN LABEL EXTENSION STUDY TO EVALUATE THE LONG TERM SAFETY AND TOLOERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRANE WITH R WITHOUT AURA | Allergan Inc. | $1,286 | 4 |
| A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRAINE | Allergan Inc. | $666.00 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,713 | 2,553 | $502,352 | $135,966 |
| 2022 | 17 | 1,466 | 2,248 | $467,560 | $125,595 |
| 2021 | 16 | 4,266 | 5,236 | $516,616 | $186,555 |
| 2020 | 16 | 2,054 | 2,896 | $398,457 | $168,930 |
Total Patients
9,499
Total Services
12,933
Medicare Billing
$617,047
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 356 | 356 | $60,876 | $48,255 | 79.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 553 | 1,268 | $351,359 | $45,739 | 13.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 143 | 143 | $11,038 | $10,122 | 91.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 38 | 39 | $7,800 | $7,644 | 98.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 145 | 203 | $40,078 | $5,891 | 14.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 155 | 155 | $6,975 | $5,005 | 71.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 18 | 18 | $5,580 | $4,022 | 72.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 19 | 19 | $3,648 | $3,307 | 90.7% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 35 | 38 | $1,824 | $1,500 | 82.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 40 | 84 | $1,932 | $1,330 | 68.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 38 | 39 | $1,521 | $1,268 | 83.3% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 46 | 54 | $2,754 | $858.60 | 31.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 71 | 76 | $3,116 | $838.94 | 26.9% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2023 | 34 | 36 | $3,276 | $106.09 | 3.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 22 | 25 | $575.00 | $79.37 | 13.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 328 | 328 | $56,088 | $45,661 | 81.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 541 | 1,255 | $335,315 | $44,779 | 13.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 30 | 34 | $10,540 | $7,807 | 74.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 88 | 91 | $6,305 | $6,191 | 98.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 138 | 176 | $33,074 | $5,274 | 15.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 92 | 96 | $4,320 | $3,062 | 70.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 17 | 17 | $3,264 | $3,034 | 92.9% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 11 | 11 | $2,860 | $2,785 | 97.4% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 13 | 13 | $3,354 | $2,343 | 69.9% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 13 | 13 | $1,585 | $1,558 | 98.3% |
About Dr. Kenneth Williams, M.D
Dr. Kenneth Williams, M.D is a Geriatric Medicine healthcare provider based in Catonsville, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649213240.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Williams, M.D has received a total of $5,672 in payments from pharmaceutical and medical device companies, with $160.76 received in 2023. These payments were reported across 251 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,700).
As a Medicare-enrolled provider, Williams has provided services to 9,499 Medicare beneficiaries, totaling 12,933 services with total Medicare billing of $617,047. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Geriatric Medicine
- Other Specialties Internal Medicine
- Location Catonsville, MD
- Active Since 06/13/2006
- Last Updated 04/27/2018
- Taxonomy Code 207RG0300X
- Entity Type Individual
- NPI Number 1649213240
Products in Payments
- FARXIGA (Drug) $354.97
- TRULICITY (Drug) $275.00
- XARELTO (Drug) $211.84
- ANORO (Drug) $200.15
- Victoza (Drug) $191.42
- BREO (Drug) $165.81
- Trintellix (Drug) $162.73
- Tresiba (Drug) $148.31
- DEXCOM G7 GSS (161) (Medical Supply) $141.14
- Ozempic (Drug) $133.30
- Truvada (Drug) $119.00
- JARDIANCE (Drug) $109.41
- TRUMENBA (Biological) $100.61
- ZOSTAVAX (Biological) $75.00
- ASMANEX (Drug) $73.01
- JANUVIA (Drug) $70.33
- ENTRESTO (Drug) $65.57
- TRELEGY ELLIPTA (Drug) $65.18
- INVOKANA (Drug) $63.25
- NUEDEXTA (Drug) $53.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Geriatric Medicine Doctors in Catonsville
Marcelino Albuerne, M.d, M.D
Geriatric Medicine — Payments: $20,786
Geriatric Medicine $20,786
Dr. Rodolfo Fernandez, M.d, M.D
Geriatric Medicine — Payments: $917.81
Geriatric Medicine $917.81
Swarupa Esanakula, M.d, M.D
Geriatric Medicine
Geriatric Medicine
Amy Mutch, Crnp, CRNP
Geriatric Medicine
Geriatric Medicine